245 related articles for article (PubMed ID: 37049555)
1. Reduction of Plasma BCAAs following Roux-en-Y Gastric Bypass Surgery Is Primarily Mediated by FGF21.
Shah H; Kramer A; Mullins CA; Mattern M; Gannaban RB; Townsend RL; Campagna SR; Morrison CD; Berthoud HR; Shin AC
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049555
[TBL] [Abstract][Full Text] [Related]
2. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
3. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.
Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y
Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491
[TBL] [Abstract][Full Text] [Related]
4. Roux-en-Y gastric bypass surgery, but not calorie restriction, reduces plasma branched-chain amino acids in obese women independent of weight loss or the presence of type 2 diabetes.
Lips MA; Van Klinken JB; van Harmelen V; Dharuri HK; 't Hoen PA; Laros JF; van Ommen GJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Dane A; Harms A; Vreeken R; Hankemeier T; Smit JW; Pijl H; Willems van Dijk K
Diabetes Care; 2014 Dec; 37(12):3150-6. PubMed ID: 25315204
[TBL] [Abstract][Full Text] [Related]
5. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
Carmody JS; Muñoz R; Yin H; Kaplan LM
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
[TBL] [Abstract][Full Text] [Related]
6. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
Rohde U
Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
[TBL] [Abstract][Full Text] [Related]
7. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
[TBL] [Abstract][Full Text] [Related]
8. Restoration of metabolic health by decreased consumption of branched-chain amino acids.
Cummings NE; Williams EM; Kasza I; Konon EN; Schaid MD; Schmidt BA; Poudel C; Sherman DS; Yu D; Arriola Apelo SI; Cottrell SE; Geiger G; Barnes ME; Wisinski JA; Fenske RJ; Matkowskyj KA; Kimple ME; Alexander CM; Merrins MJ; Lamming DW
J Physiol; 2018 Feb; 596(4):623-645. PubMed ID: 29266268
[TBL] [Abstract][Full Text] [Related]
9. Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice.
Boland BB; Mumphrey MB; Hao Z; Townsend RL; Gill B; Oldham S; Will S; Morrison CD; Yu S; Münzberg H; Rhodes CJ; Trevaskis JL; Berthoud HR
Mol Metab; 2019 Jul; 25():64-72. PubMed ID: 31126840
[TBL] [Abstract][Full Text] [Related]
10. Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats.
Mosinski JD; Aminian A; Axelrod CL; Batayyah E; Romero-Talamas H; Daigle C; Mulya A; Scelsi A; Schauer PR; Brethauer SA; Kirwan JP
Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E392-E398. PubMed ID: 33427046
[TBL] [Abstract][Full Text] [Related]
11. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
[TBL] [Abstract][Full Text] [Related]
12. Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels.
Lindqvist A; Ekelund M; Pierzynowski S; Groop L; Hedenbro J; Wierup N
Peptides; 2017 Apr; 90():78-82. PubMed ID: 28242256
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat.
Meirelles K; Ahmed T; Culnan DM; Lynch CJ; Lang CH; Cooney RN
Ann Surg; 2009 Feb; 249(2):277-85. PubMed ID: 19212182
[TBL] [Abstract][Full Text] [Related]
14. The PYY/Y2R-Deficient Mouse Responds Normally to High-Fat Diet and Gastric Bypass Surgery.
Boland B; Mumphrey MB; Hao Z; Gill B; Townsend RL; Yu S; Münzberg H; Morrison CD; Trevaskis JL; Berthoud HR
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30857366
[TBL] [Abstract][Full Text] [Related]
15. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
[TBL] [Abstract][Full Text] [Related]
16. Peptide Tyrosine-Tyrosine Triggers GLP-2-Mediated Intestinal Hypertrophy After Roux-en-Y Gastric Bypass.
Pérez-Arana GM; Díaz-Gómez A; Camacho-Ramírez A; Ribelles-García A; Almorza-Gomar D; Gracia-Romero M; Prada-Oliveira JA
Obes Surg; 2022 Dec; 32(12):4023-4032. PubMed ID: 36301409
[TBL] [Abstract][Full Text] [Related]
17. Effect of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding on branched-chain amino acid metabolism.
Magkos F; Bradley D; Schweitzer GG; Finck BN; Eagon JC; Ilkayeva O; Newgard CB; Klein S
Diabetes; 2013 Aug; 62(8):2757-61. PubMed ID: 23610059
[TBL] [Abstract][Full Text] [Related]
18. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
[TBL] [Abstract][Full Text] [Related]
19. Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
Nguyen KT; Billington CJ; Vella A; Wang Q; Ahmed L; Bantle JP; Bessler M; Connett JE; Inabnet WB; Thomas A; Ikramuddin S; Korner J
Diabetes; 2015 Sep; 64(9):3104-10. PubMed ID: 25901097
[TBL] [Abstract][Full Text] [Related]
20. Peptide-YY
Boland BB; Laker RC; O'Brien S; Sitaula S; Sermadiras I; Nielsen JC; Barkholt P; Roostalu U; Hecksher-Sørensen J; Sejthen SR; Thorbek DD; Suckow A; Burmeister N; Oldham S; Will S; Howard VG; Gill BM; Newton P; Naylor J; Hornigold DC; Austin J; Lantier L; McGuinness OP; Trevaskis JL; Grimsby JS; Rhodes CJ
Mol Metab; 2022 Jan; 55():101392. PubMed ID: 34781035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
